NCT00970502 2017-04-10Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck CancerIcahn School of Medicine at Mount SinaiPhase 1/2 Completed15 enrolled 16 charts
NCT00140556 2013-01-18Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck CancerDuke UniversityPhase EARLY_PHASE1 Completed28 enrolled 8 charts